FDA | GovernmentCIO Media & Research


FDA's post-surveillance methods ensure the continued safety of a vaccine through the collection and monitoring of health data.
The last thing federal agencies, especially health agencies, should do is allow their cyber vigilance to slip.
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
The agency is updating its guidance around vaccine authorization and will require investments in technology for its distribution.
NIH, CDC and FDA leaders see health data sharpening government's understanding of COVID-19.